LZTR1 mutations have also been associated with Noonan syndrome (NS), a type of RASopathy affecting multiple organ systems, including growth, craniofacial, cardiovascular, and neurocognitive abnormalities (Yamamoto et al., 2015). Here, LZTR1 is linked to RASopathy.